A Study of ICP-192 in Patients With Advanced Solid Tumors

NCT04565275 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

45

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors
Urothelial Carcinoma
Cholangiocarcinoma

Interventions

DRUG: Drug ICP-192

Sponsor

Beijing InnoCare Pharma Tech Co., Ltd.